These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5801655)

  • 1. [A ray of hope for leukemia and neoplasms].
    Kurz JF
    Z Allgemeinmed; 1969 May; 45(13):627-9. PubMed ID: 5801655
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antileukemic activity of asparaginase].
    Guglielmi G; Iaschi P
    Clin Ter; 1969 Dec; 51(5):481-4. PubMed ID: 5382106
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)].
    Nikolaev AIa
    Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):51-60. PubMed ID: 4903458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A; Szyszka K; Abucewicz A
    Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antineoplastic activity of various bacterial enzyme preparations].
    Pszczólska G; Krzemiński Z
    Pol Tyg Lek; 1969 Oct; 24(43):1660-3. PubMed ID: 4901697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enzyme therapy of malignant tumors].
    Jacobasch KH
    Arch Geschwulstforsch; 1969; 34(4):364-75. PubMed ID: 4920119
    [No Abstract]   [Full Text] [Related]  

  • 7. [Asparaginase and acute leukemia].
    Benbenishti D
    Harefuah; 1971 Feb; 80(3):156. PubMed ID: 5099261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Asparaginase: a new element in the treatment of acute leukemia?].
    Teulings FA; Bakkeren JM
    Ned Tijdschr Geneeskd; 1970 Jul; 114(27):1137-40. PubMed ID: 4915105
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-asparaginase in leukemia].
    Böttiger LE
    Nord Med; 1967 Nov; 78(46):1521. PubMed ID: 6065209
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of response to L-asparaginase therapy.
    Prager MD
    Natl Cancer Inst Monogr; 1971 Dec; 34():257-62. PubMed ID: 5140872
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical and genetic aspects of the use of L-asparaginase as an antileukemic factor].
    Medvedev ZhA
    Usp Sovrem Biol; 1971; 71(2):208-19. PubMed ID: 4935597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
    Zhou J; Jin H; Li Y; Jiang T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [L-asparaginase, a new drug of antileukemic action].
    Hernádi F
    Orv Hetil; 1969 Jan; 110(4):187-9. PubMed ID: 5779083
    [No Abstract]   [Full Text] [Related]  

  • 14. L-asparaginase--antileukemia agent.
    Yaqub M
    J Pak Med Assoc; 1975 Mar; 25(3):56-8. PubMed ID: 814292
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of L-asparaginase therapy].
    Minerva Med; 1971 Oct; 62(79):20-1. PubMed ID: 5112256
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of acute leukemias with L-asparaginase].
    Senn HJ
    Praxis; 1969 May; 58(21):669-70. PubMed ID: 5819625
    [No Abstract]   [Full Text] [Related]  

  • 17. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD
    Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction to New Drug Seminar: Daunorubicin and L-asparaginase.
    Weiss RB; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():1-2. PubMed ID: 7049372
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive effect of L-asparaginase].
    Emmerling P; Finger H
    Dtsch Med Wochenschr; 1970 Jul; 95(30):1578-9. PubMed ID: 5431973
    [No Abstract]   [Full Text] [Related]  

  • 20. Eighth new drug seminar on l-asparaginase and daunorubicin. Division of Cancer Treatment. National Cancer Institute. December 17, 1979 Bethesda, Maryland.
    Cancer Treat Rep; 1981; 65 Suppl 4():1-130. PubMed ID: 7346157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.